Enveric Biosciences, Inc. (ENVB)

1.47 +0.06 (+4.26%) USD  |  NASDAQ  |  Aug 25, 16:00
1.47 0.00 (0.00%) After-Hours: 18:25
More

Enveric Biosciences Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for ENVB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
March 06, 2025 --
December 31, 2024 --
August 01, 2024 --
April 02, 2024 --
January 30, 2024 --
Date Value
December 31, 2023 --
December 29, 2023 --
November 20, 2023 --
October 03, 2023 --
August 24, 2023 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
LENZ Therapeutics, Inc. Upgrade
Impact BioMedical, Inc. --
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade